Burrows Family Practice, Inc. | |
1377 S Grand Ave Glendora CA 91740-5047 | |
(626) 483-3348 | |
(626) 623-7258 |
Full Name | Burrows Family Practice, Inc. |
---|---|
Speciality | Family Medicine |
Location | 1377 S Grand Ave, Glendora, California |
Authorized Official Name and Position | Toni Muus (OFFICE MANAGER) |
Authorized Official Contact | 6264833348 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Burrows Family Practice, Inc. 1377 S Grand Ave Glendora CA 91740-5047 Ph: (626) 483-3348 | Burrows Family Practice, Inc. 1377 S Grand Ave Glendora CA 91740-5047 Ph: (626) 483-3348 |
NPI Number | 1003361890 |
---|---|
Provider Enumeration Date | 08/22/2016 |
Last Update Date | 01/19/2017 |
Medicare PECOS PAC ID | 3678861457 |
---|---|
Medicare Enrollment ID | O20161011001395 |
News Archive
International Medical News Group, LLC, an Elsevier company that provides medical news and information to physicians, announced today the launch of Cardiology Product Zone. This new product resource guide is launched in partnership with Pure Incubation, a company that specializes in developing data driven web properties and performance media programs that are focused exclusively on the product buying process.
The ultra-stable properties of the proteins that allow deep-diving whales to remain active while holding their breath for up to two hours could help Rice University biochemist John Olson and his colleagues finish a 20-year quest to create lifesaving synthetic blood for human trauma patients.
If your father and grandfather waited until they were older before reproducing, you might experience life-extending benefits. Biologists assume that a slow pace of aging requires that the body invest more resources in repairing cells and tissues.
Physicians treating hospitalized patients for conditions unrelated to the kidneys should pay close attention to common blood and urine tests for kidney function in order to prevent incidental injury to the organs that help cleanse the body of toxins, new Johns Hopkins Bloomberg School of Public Health-led research suggests.
ARIAD Pharmaceuticals, Inc. today announced that the independent Data Monitoring Committee (DMC) of the Phase 3 SUCCEED trial has completed the second interim efficacy analysis as specified in the study protocol and has recommended that the randomized, placebo-controlled trial of oral ridaforolimus in patients with metastatic sarcomas continue to its final analysis, without modification to the study protocol.
› Verified 9 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1003361890 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
207Q00000X | Family Medicine | A43321 (California) | Primary |
Provider Name | Oliver M Burrows |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1033157979 PECOS PAC ID: 6709913791 Enrollment ID: I20100422001047 |
News Archive
International Medical News Group, LLC, an Elsevier company that provides medical news and information to physicians, announced today the launch of Cardiology Product Zone. This new product resource guide is launched in partnership with Pure Incubation, a company that specializes in developing data driven web properties and performance media programs that are focused exclusively on the product buying process.
The ultra-stable properties of the proteins that allow deep-diving whales to remain active while holding their breath for up to two hours could help Rice University biochemist John Olson and his colleagues finish a 20-year quest to create lifesaving synthetic blood for human trauma patients.
If your father and grandfather waited until they were older before reproducing, you might experience life-extending benefits. Biologists assume that a slow pace of aging requires that the body invest more resources in repairing cells and tissues.
Physicians treating hospitalized patients for conditions unrelated to the kidneys should pay close attention to common blood and urine tests for kidney function in order to prevent incidental injury to the organs that help cleanse the body of toxins, new Johns Hopkins Bloomberg School of Public Health-led research suggests.
ARIAD Pharmaceuticals, Inc. today announced that the independent Data Monitoring Committee (DMC) of the Phase 3 SUCCEED trial has completed the second interim efficacy analysis as specified in the study protocol and has recommended that the randomized, placebo-controlled trial of oral ridaforolimus in patients with metastatic sarcomas continue to its final analysis, without modification to the study protocol.
› Verified 9 days ago
News Archive
International Medical News Group, LLC, an Elsevier company that provides medical news and information to physicians, announced today the launch of Cardiology Product Zone. This new product resource guide is launched in partnership with Pure Incubation, a company that specializes in developing data driven web properties and performance media programs that are focused exclusively on the product buying process.
The ultra-stable properties of the proteins that allow deep-diving whales to remain active while holding their breath for up to two hours could help Rice University biochemist John Olson and his colleagues finish a 20-year quest to create lifesaving synthetic blood for human trauma patients.
If your father and grandfather waited until they were older before reproducing, you might experience life-extending benefits. Biologists assume that a slow pace of aging requires that the body invest more resources in repairing cells and tissues.
Physicians treating hospitalized patients for conditions unrelated to the kidneys should pay close attention to common blood and urine tests for kidney function in order to prevent incidental injury to the organs that help cleanse the body of toxins, new Johns Hopkins Bloomberg School of Public Health-led research suggests.
ARIAD Pharmaceuticals, Inc. today announced that the independent Data Monitoring Committee (DMC) of the Phase 3 SUCCEED trial has completed the second interim efficacy analysis as specified in the study protocol and has recommended that the randomized, placebo-controlled trial of oral ridaforolimus in patients with metastatic sarcomas continue to its final analysis, without modification to the study protocol.
› Verified 9 days ago
Valley Gastoenterology Consultants Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 415 W Carroll Ave, Suite 201, Glendora, CA 91741 Phone: 626-963-2490 Fax: 626-963-2495 | |
Marc Gutin M D Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 210 S Grand Ave, Suite 224, Glendora, CA 91741 Phone: 626-335-8094 Fax: 626-335-1874 | |
Nalini Singh Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 412 W Carroll Ave Ste 106, Glendora, CA 91741 Phone: 626-244-8170 | |
Devesh N Patel,md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 130 W Route 66, Suite 302, Glendora, CA 91740 Phone: 626-914-1514 Fax: 626-914-1505 | |
Krunal J Mehta Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 130 W Route 66 Ste 214, Glendora, CA 91740 Phone: 626-335-4129 Fax: 626-335-6177 | |
Nilesh N. Patel Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 130 W Route 66 Ste 302, Glendora, CA 91740 Phone: 626-914-1514 Fax: 626-914-1505 |